Piper Jaffray Companies cut shares of Imperva Inc (NYSE:IMPV) from an overweight rating to a neutral rating in a research report released on Monday, October 16th, MarketBeat.com reports. The firm currently has $42.00 target price on the software maker’s stock.
Several other equities analysts have also recently commented on IMPV. Evercore ISI set a $56.00 price target on shares of Imperva and gave the company a buy rating in a report on Thursday, August 10th. Zacks Investment Research cut shares of Imperva from a strong-buy rating to a hold rating in a report on Wednesday, September 27th. BidaskClub upgraded shares of Imperva from a sell rating to a hold rating in a report on Tuesday, August 22nd. Imperial Capital lowered their price target on shares of Imperva from $57.00 to $50.00 and set an outperform rating on the stock in a report on Tuesday, October 10th. Finally, Stifel Nicolaus reaffirmed a hold rating and issued a $47.00 price objective on shares of Imperva in a research note on Friday, July 14th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. Imperva currently has an average rating of Buy and an average price target of $51.23.
Shares of Imperva (NYSE IMPV) opened at 41.75 on Monday. The firm’s market capitalization is $1.41 billion. The company’s 50-day moving average price is $43.69 and its 200 day moving average price is $45.94. Imperva has a 12-month low of $34.40 and a 12-month high of $52.40.
Imperva (NYSE:IMPV) last posted its quarterly earnings data on Thursday, July 27th. The software maker reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.15). Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The firm had revenue of $74.44 million for the quarter, compared to analysts’ expectations of $74.30 million. During the same quarter in the previous year, the firm posted ($0.23) earnings per share. The company’s revenue for the quarter was up 28.6% on a year-over-year basis. On average, equities research analysts forecast that Imperva will post $0.85 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Imperva Inc (IMPV) Cut to Neutral at Piper Jaffray Companies” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another domain, it was stolen and reposted in violation of international copyright & trademark law. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2017/10/28/piper-jaffray-companies-lowers-imperva-inc-impv-to-neutral.html.
In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of the company’s stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the sale, the director now directly owns 99,598 shares of the company’s stock, valued at $4,341,476.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 2.20% of the stock is currently owned by corporate insiders.
Several hedge funds have recently made changes to their positions in IMPV. Bank of New York Mellon Corp lifted its position in shares of Imperva by 1.9% during the first quarter. Bank of New York Mellon Corp now owns 125,398 shares of the software maker’s stock worth $5,148,000 after purchasing an additional 2,295 shares in the last quarter. Comerica Bank acquired a new position in Imperva in the first quarter valued at approximately $850,000. UBS Asset Management Americas Inc. lifted its holdings in Imperva by 107.3% in the first quarter. UBS Asset Management Americas Inc. now owns 13,889 shares of the software maker’s stock valued at $570,000 after buying an additional 7,189 shares during the period. Karp Capital Management Corp acquired a new position in Imperva in the first quarter valued at approximately $270,000. Finally, Ameritas Investment Partners Inc. acquired a new position in Imperva in the first quarter valued at approximately $102,000. Institutional investors own 92.72% of the company’s stock.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.